Jeff Cook Real Estate LPT Realty Named A Winner of the South Carolina Top Workplaces 2024 Award for Sixth Consecutive Year
Jeff Cook Real Estate LPT Realty Named A Winner of the South Carolina Top Workplaces 2024 Award for Sixth Consecutive Year
May 03, 2024 17:19 ET | Jeff Cook Real Estate
Columbia, SC, May 03, 2024 (GLOBE NEWSWIRE) -- The South Carolina Top Workplaces have awarded Jeff Cook Real Estate LPT Realty a Top Workplaces 2024 honor for the 6th consecutive year. This list is...
RM Primary Logo - Humble.png
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
April 08, 2024 11:36 ET | Revolution Medicines, Inc.
Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that exhibits unprecedented anti-tumor activity in...
Dyadic Logo Current.jpg
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
March 26, 2024 08:30 ET | Dyadic International, Inc.
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models compared to monoclonal antibody produced in CHO. ...
AB Science : De nouv
AB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmune
March 13, 2024 07:59 ET | AB Science
COMMUNIQUÉ DE PRESSE DE NOUVELLES RECHERCHES MONTRENT QUE LE MASITINIB LIMITE LES DOMMAGES NEURONAUX DANS UN MODÈLE DE MALADIE NEURODÉGÉNÉRATIVE D'ORIGINE NEUROIMMUNE C'EST LA PREMIÈRE FOIS QUE LE...
AB Science: New rese
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
March 13, 2024 07:59 ET | AB Science
PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS THE FIRST DEMONSTRATION THAT MASITINIB CAN LOWER SERUM...
SFWJLogo.png
SFWJ DBA MedCana Names Seasoned Agri-Tech Leader Paula Restrepo as Sales Director for Subsidiary Eko20 S.A.S.
February 28, 2024 08:45 ET | Software Effective Solutions Corp. (d/b/a MedCana)
AUSTIN, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via IBN – SFWJ dba MedCana announces that Eko2o S.A.S., a majority controlled subsidiary of MedCana/SFWJ in Colombia and a leading provider of...
Jeff Cook Real Estate LPT Realty Highlights 2023 Top Agents of Quarter 4
Jeff Cook Real Estate LPT Realty Highlights 2023 Top Agents of Quarter 4
January 25, 2024 16:41 ET | Jeff Cook Real Estate
Charleston, SC, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Jeff Cook Real Estate LPT Realty is excited to highlight its top agents in the fourth quarter of 2023. Through the ups and downs of the current real...
Jeff Cook Real Estate Highlights 2023 Top Agents of Quarter 3
Jeff Cook Real Estate Highlights 2023 Top Agents of Quarter 3
November 29, 2023 12:07 ET | Jeff Cook Real Estate
Charleston, SC, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Jeff Cook Real Estate LPT Realty is excited to highlight its top agents in the third quarter of 2023. The real estate market continues to shift and...
logo.png
Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
October 16, 2023 08:11 ET | Silo Pharma, Inc.
Human tissue study assessed SPU-21’s efficiency, optimization, and binding affinity ENGLEWOOD CLIFFS, NJ, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a...
scilogo.jpg
SciSparc Granted European Patent for its Core Technology
October 03, 2023 07:33 ET | SciSparc Ltd
The receipt of the patent confirms the innovation and uniqueness of the Company's technologies and strengthens its position as a leader in the cannabis space TEL AVIV, Israel, Oct. 03, 2023 ...